To evaluate the therapeutic efficacy of PMI-Au SNH in vivo, we used a xenograft tumor model in which HCT116 p53+/+ cells were subcutaneously inoculated to the flank of BALB/c nude mice. Here, TP53 is linked to neoplasm.